28 Jul 2026Open access
Maternal 6-valent group B Streptococcus vaccine in non-pregnant and pregnant females: a randomized phase 1/2 trialPublisher siteNature Medicine, Neonatal and Maternal Infections
Active, last published 2026
In hiv/aids research and interventions
Lee
Fairlie
Scholar“Research focused on HIV/AIDS Research and Interventions and adjacent fields.”
University of the Witwatersrand
South Africa37
H-index
13.4k
Citations
Lee has not officially claimed their profile. If you are Lee, claim it free.
Claim Your Profile
Pioneer
LOCKED
Pathfinder
LOCKED
Scholar
EARNED
Innovator
LOCKED
Inventor
LOCKED
Catalyst
LOCKED
Expert
UPGRADE
01 · About the work
What I study
ee Fairlie is a researcher working on HIV/AIDS Research and Interventions. A fuller summary will appear once they update their profile.
02 · Reach
Publication output and reach
Lee's work has been cited 13,401 times across 3 active years. Bars show publications per year; the line shows cumulative citation totals across publications first appearing in each year.
03 · Research focus
Topics
HIV/AIDS Research and Interventions×77HIV/AIDS drug development and treatment×53SARS-CoV-2 and COVID-19 Research×33HIV Research and Treatment×29HIV-related health complications and treatments×26
04 · Where I am
Affiliations
Affiliation on published researchUniversity of the Witwatersrand, South AfricaDrawn from the institution listed on this researcher’s published work.
Research themes (UN SDGs)
05 · Selected work
Recent publications
22 works1 Jun 2026Open access
Vaginal Microbiota and Cytokines Among Pregnant and Breastfeeding Women in Clinical Trials of the Dapivirine Vaginal Ring and Oral Tenofovir Disoproxil Fumarate/EmtricitabinePublisher siteOpen Forum Infectious Diseases, Reproductive tract infections research
1 Jun 2026Open access
Opportunities and Challenges for Surveillance of Congenital Anomalies in Sub‐Saharan AfricaPublisher siteBirth Defects Research, Global Health and Surgery
29 May 2026
Rethinking HIV antibody testing in children aged 18-24 months in the OPPTIM study conducted in Johannesburg, South Africa 2018-2021Publisher siteDiagnostic Microbiology and Infectious Disease, HIV/AIDS Research and Interventions
26 May 2026Open access
Low seroprevalence of neutralizing antibodies to gorilla adenovirus 32 (GRAd32) in southern African populations supports evaluation of this vector platform for HIV vaccine developmentPublisher sitebioRxiv (Cold Spring Harbor Laboratory), Virus-based gene therapy research
14 May 2026
Letter Reply to “Mind the Postpartum Trough: Closing the Clofazimine Exposure Gap After Delivery in Rifampicin-Resistant Tuberculosis”Publisher siteThe Journal of Infectious Diseases, Tuberculosis Research and Epidemiology
12 Dec 2024Open access2cites
Immunogenicity and safety following a homologous booster dose of a SARS-CoV-2 recombinant spike protein vaccine with Matrix-M <sup>TM</sup> adjuvant (NVX-CoV2373) versus a primary series in people living with and without HIV-1 infection in South Africa: A randomized crossover phase 2a/2b trialPublisher siteHuman Vaccines & Immunotherapeutics, SARS-CoV-2 and COVID-19 Research
6 Nov 2024Open access3cites
Measles–Rubella Microarray Patches Phase III Clinical Trial Framework: Proposal and ConsiderationsPublisher siteVaccines, Virology and Viral Diseases
Expert Academic Profiles go further
Citation trend analytics, exportable publication records, and direct enquiry routing from industry and funders.
Are you Lee?
Claim it to verify your details, connect with industry partners, and explore Fractional Domain Expert opportunities through MARATTO™.
African researchers are full of potential that too often goes unrecognised. Your MARATTO™ profile gives your work the commercial pathway it deserves.
Claim Your Profile
Free to claim · takes a minute to verify it’s you